Multivariate analysis of change in spherical equivalent demonstrated that the hyperopic shift ( 0.20 D ) noted in atropine-treated eyes between baseline and 4 months , and the myopic rebound ( -0.74 D ) noted between 24 to 30 months when atropine was stopped , were associated with a reduction and increase in VCD and AL , respectively , after adjusting for age and sex .